Brustugun OT - Search Results

1

PIK3CA mutations as prognostic factor in squamous cell lung carcinoma.

McGowan M, Hoven AS, Lund-Iversen M, Solberg S, Helland Å, Hirsch FR, Brustugun OT. McGowan M, et al. Among authors: brustugun ot. Lung Cancer. 2017 Jan;103:52-57. doi: 10.1016/j.lungcan.2016.11.018. Epub 2016 Nov 28. Lung Cancer. 2017. PMID: 28024696

2

[Lung cancer in smokers and never-smokers].

Helland A, Brustugun OT. Helland A, et al. Among authors: brustugun ot. Tidsskr Nor Laegeforen. 2009 Sep 24;129(18):1859-62. doi: 10.4045/tidsskr.08.0652. Tidsskr Nor Laegeforen. 2009. PMID: 19844277 Free article. Review. Norwegian.

3

Excessive Soft Tissue Reaction after Stereotactic Body Radiation Therapy in a Woman with Four Different Cancer Diagnoses.

Turzer M, Brustugun OT, Helland A. Turzer M, et al. Among authors: brustugun ot. Case Rep Oncol. 2010 Jun 26;3(2):195-201. doi: 10.1159/000317104. Case Rep Oncol. 2010. PMID: 20740196 Free PMC article.

4

Sex-specific trends in lung cancer incidence and survival: a population study of 40,118 cases.

Sagerup CM, Småstuen M, Johannesen TB, Helland Å, Brustugun OT. Sagerup CM, et al. Among authors: brustugun ot. Thorax. 2011 Apr;66(4):301-7. doi: 10.1136/thx.2010.151621. Epub 2011 Jan 2. Thorax. 2011. PMID: 21199818

5

Stereotactic body radiation therapy is effective and safe in patients with early-stage non-small cell lung cancer with low performance status and severe comorbidity.

Turzer M, Brustugun OT, Waldeland E, Helland A. Turzer M, et al. Among authors: brustugun ot. Case Rep Oncol. 2011 Jan 21;4(1):25-34. doi: 10.1159/000324113. Case Rep Oncol. 2011. PMID: 21526003 Free PMC article.

6

EGFR gene alterations in a Norwegian cohort of lung cancer patients selected for surgery.

Helland Å, Skaug HM, Kleinberg L, Iversen ML, Rud AK, Fleischer T, Sagerup C, Solberg S, Jørgensen L, Ariansen S, Brustugun OT. Helland Å, et al. Among authors: brustugun ot. J Thorac Oncol. 2011 May;6(5):947-50. doi: 10.1097/JTO.0b013e31820db209. J Thorac Oncol. 2011. PMID: 21623266 Free article.

7

Palmar bullous blistering induced by erlotinib.

Berg A, Brustugun OT, Lund-Iversen M, Helland Å. Berg A, et al. Among authors: brustugun ot. J Thorac Oncol. 2011 May;6(5):954. doi: 10.1097/JTO.0b013e318211136b. J Thorac Oncol. 2011. PMID: 21623268 Free article. No abstract available.

8

Dynamic respiratory gated (18)FDG-PET of lung tumors - a feasibility study.

Knudtsen IS, Rødal J, Brustugun OT, Helland Å, Skretting A, Malinen E. Knudtsen IS, et al. Among authors: brustugun ot. Acta Oncol. 2011 Aug;50(6):889-96. doi: 10.3109/0284186X.2011.583266. Acta Oncol. 2011. PMID: 21767189

9

Increasing age and carcinoma not otherwise specified: a 20-year population study of 40,118 lung cancer patients.

Sagerup CM, Småstuen M, Johannesen TB, Helland A, Brustugun OT. Sagerup CM, et al. Among authors: brustugun ot. J Thorac Oncol. 2012 Jan;7(1):57-63. doi: 10.1097/JTO.0b013e3182307f7e. J Thorac Oncol. 2012. PMID: 21900838 Free article.

10

Dosimetric impact of a frame-based strategy in stereotactic radiotherapy of lung tumors.

Waldeland E, Ramberg C, Arnesen MR, Helland A, Brustugun OT, Malinen E. Waldeland E, et al. Among authors: brustugun ot. Acta Oncol. 2012 May;51(5):603-9. doi: 10.3109/0284186X.2012.658115. Epub 2012 Feb 6. Acta Oncol. 2012. PMID: 22304490

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page